Funding Corner

The goal of the NHLBI Progenitor Cell Translational Consortium (PCTC) is to translate advances in progenitor cell biology towards application to heart, lung, and blood diseases. We also try to gather relevant funding opportunities for the consortium.

To suggest funding opportunities for inclusion here, contact PCTC Administrative staff, Andrea Lefever ( and Ling Tang (



To access all the latest NHLBI related fundings, click HERE.


Copyright ©2016 NHLBI Progenitor Cell Translational Consortium.

University of Maryland School of Medicine logo

National Heart Blood and Lung Institute logo